Peripheral Neuropathy Trial, Recruiting NCT07264426 Sponsor: argenx Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07264426
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time they give their consent to join the study
  • People who have been diagnosed with a condition called CIDP (a nerve disease that causes muscle weakness and impaired sensory function)
  • People whose doctor plans to treat them with a medicine called efgartigimod, in line with how that medicine is approved for use in their country
  • People who have never previously been treated with efgartigimod

Who may not be able to join:

  • People whose nerve condition is caused by something other than CIDP
  • People who are currently taking part in another clinical trial, or who plan to join another clinical trial before starting efgartigimod treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 857-350-4834

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
argenx
Registry
ClinicalTrials.gov
Start date
11 August 2025
Est. completion
1 October 2029

Where this trial is recruiting

🇩🇪 Germany 🇺🇸 United States

Primary endpoints

Change in aINCAT score over time; Change in I-RODS score over time; Change in grip strength over time; Change in EQ-5D value from index date over time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov